Exciva is a biopharmaceutical company delivering treatment to address symptoms of Alzheimer’s patients. It offers a product Deraphan that treats behavioral and psychological symptoms in Alzheimer's disease patients. The company provides programs for developing disease-modifying therapies, cures, prophylactics, supplements, formulations, and methods of making and using such compositions.